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Purpose: To map and identify the genetic defect underlying autosomal dominant cataract segregating in a 5-generation
Caucasian American family.
Methods: Genomic DNA was prepared from blood leukocytes, genotyping was performed using microsatellite markers,
and logarithm of the odds (LOD) scores were calculated using the LINKAGE programs. Mutation profiling was performed
using direct exon cycle-sequencing and restriction fragment analysis. Protein function effects were evaluated using in
silico prediction algorithms.
Results: Significant evidence of linkage was obtained at marker D13S175 (maximum LOD score [Zmax]=3.67; maximum
recombination fraction [θmax]=0.04) and D13S1316 (Zmax=2.80, θmax=0.0). Haplotyping indicated that the disease lay in
the ~170 Kb physical interval between D13S1316 and D13S175, which contained the gene for gap-junction protein alpha-3
(GJA3) or connexin-46. Sequencing of GJA3 detected a heterozygous transition (c.130G>A) in exon-2 that resulted in
gain of an Hsp92 II restriction site. Allele-specific PCR amplification and restriction analysis confirmed that the novel
Hsp92 II site co-segregated with cataract in the family but was not detected in 192 normal unrelated individuals. The c.
130G>A transition  was    predicted to result in a  non-conservative  substitution   of valine-to-methionine  at  codon   44
(p.V44M) with damaging effects on protein function.
Conclusions: These data confirm GJA3 as one of the most frequently mutated genes that underlie autosomal dominant
cataract in humans, and further emphasize the importance of connexin function in maintaining lens transparency.
Inherited  forms  of  cataract(s)  constitute  a  clinically
heterogeneous disorder of the ocular lens that usually present
with an early-onset ranging from birth (congenital) through
infancy into the fourth decade (Online Mendelian Inheritance
in Man; OMIM). Congenital and infantile forms of cataract
that cause blurring of images on the immature retina are a
clinically  important  cause  of  impaired  form  vision
development (deprivation amblyopia), and pediatric cataract
surgery is associated with increased risk of aphakic glaucoma
and lifelong visual impairment [1-3].
In addition to being found as a secondary feature of many
genetic syndromes and metabolic disorders involving other
ocular and/or systemic abnormalities (OMIM), cataract may
be inherited as a primary or isolated lens phenotype [4,5]. All
three  classical  forms  of  Mendelian  inheritance  have  been
described. However, most families reported exhibit autosomal
dominant transmission with high penetrance. So far genetic
linkage  studies  of  around  180  families  worldwide  have
mapped at least 35 independent loci and identified mutations
in over 20 genes for phenotypically diverse forms of primary
cataract involving total, nuclear, lamellar/zonular, sutural, and
polar/sub-capsular lens opacities [6].
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Approximately 55% of the known mutations underlying
inherited forms of primary cataract have been detected in ten
crystallin  genes;  alphaA-crystallin  (CRYAA),  alphaB-
crystallin  (CRYAB),  betaB1-crystallin  (CRYBB1),  betaB2-
crystallin (CRYBB2), betaB3-crystallin (CRYBB3), betaA1-
crystallin (CRYBA1), bataA4-crystallin (CRYBA4), gammaC-
crystallin  (CRYGC),  gammaD-crystallin  (CRYGD),  and
gammaS-crystallin  (CRYGS)  that  encode  the  major
“refractive” proteins of the lens [7-15]. A further 20–25% of
known mutations have been detected in two genes encoding
gap-junction protein alpha 3 and alpha 8 (GJA3,GJA8) [16,
17]. The remainder of underlying mutations occur in a group
of functionally diverse genes including those for; heat-shock
transcription factor 4 (HSF) [18], lens major intrinsic protein
(MIP) [19], lens intrinsic membrane protein 2 (LIM2) [20],
transmembrane  protein  114  (TMEM114)  [21],  beaded
filament structural protein 1 and protein 2 (BFSP1,BFSP2)
[22,23], chromatin modifying protein 4B (CHMP4B) [24],
Eph-receptor  type  A2  (EPHA2)  [25],  Tudor  domain
containing  7  (TDRD7)  [26],  and  FYVE  and  coiled-coil
domain containing 1 (FYCO1) [27]. Here we have mapped
autosomal  dominant  cataract  segregating  in  a  Caucasian
American  family  to  chromosome  13q  and  identified  a
missense  mutation  in  the  gene  for  gap-junction  protein
alpha-3 (GJA3), or connexin-46.
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Family  participants:  A  5-generation  Caucasian  pedigree
(family  Sh)  from  the  midwestern  United  States  was
ascertained through ophthalmic records in the Department of
Ophthalmology  and  Visual  Sciences  at  Washington
University School of Medicine, St. Louis MO. Blood samples
were obtained from 22 family members including 11 affected
individuals. Leukocyte genomic DNA was purified using the
Gentra  Puregene  Blood  kit  (Qiagen,  Valencia,  CA),  and
quantified by absorbance at 260 nm (NanoDrop 2000; Thermo
Fisher Scientific, Wilmington, DE). Ethical approval for this
study was obtained from the Washington University Human
Research Protection Office, and written informed consent was
provided by all participants before enrollment in accordance
with the tenets of the Declaration of Helsinki, and Health
Insurance  Portability  and  Accountability  Act  (HIPAA)
regulations.
Genotyping  and  linkage  analysis:  Microsatellite  markers
from  the  National  Center  for  Biotechnology  Information
(NCBI)  combined  Généthon,  Marshfield,  and  deCODE
genetic linkage maps were genotyped by means of a 4200
DNA  analyzer  running  Gene  ImagIR  software  (Li-Cor,
Lincoln, NE) as described [28]. Pedigree and haploptype data
were managed using Cyrillic (v.2.1) software (FamilyGenetix
Ltd.,  Reading,  UK),  and  two-point  logarithm  of  the  odds
(LOD) scores (Z) calculated using the MLINK sub-program
from the LINKAGE (5.1) package of programs [29]. Marker
allele  frequencies  were  assumed  to  be  equal,  and  a  gene
frequency of 0.0001 with a penetrance of 100% were assumed
for the disease locus.
Sequencing  analysis:  Genomic  sequence  for  GJA3  was
obtained from the Ensemble human genome browser, and
gene-specific  M13-tailed  PCR  primers  (Table  1)  were
selected from the NCBI re-sequencing amplicon (RSA) probe
database or custom designed (IDT Primer Quest). Genomic
DNA  (2.5  ng/μl,  20  μl  reactions),  was  amplified  (35–40
cycles) in a GeneAmp 9700 thermal cycler using AmpliTaq
polymerase (Applied Biosystems, Foster City, CA) and gene-
specific primers (10 pmol). Resulting PCR amplicons were
either enzyme-purified with ExoSAP-IT (USB Corporation,
Cleveland,  OH)  or  gel-purified  with  the  QIAquick  gel-
extraction kit (Qiagen). Purified amplicons were direct cycle-
sequenced in both directions with BigDye Terminator Ready
Reaction Mix (version 3.1) containing M13 forward or reverse
sequencing primers then ethanol precipitated and detected by
capillary  electrophoresis  on  a  3130xl  Genetic  Analyzer
running Sequence Analysis (version 5.2) software (Applied
Biosystems),  and  Chromas  (version  2.23)  software
(Technelysium, Tewantin, Queensland, Australia).
Restriction  analysis:  Allele-specific  restriction  fragment
length  analysis  was  performed  on  gel-purified  PCR
amplicons, amplified with primers GJA3-Ex2F1 and GJA3-
Ex2R1 (Table 1) using Hsp92 II at 37 °C for 1 h according to
the manufacturer’s instructions (Promega, Madison, WI), and
digestion  products  were  visualized  at  302  nm  following
electrophoresis  in  3%  agarose-gels  stained  with  GelRed
(Biotium,  Hayward,  CA).  In  addition  to  family  Sh,  we
extended  Hsp92  II  restriction  analysis  to  include  192
unrelated individuals from the European Collection of Animal
Cell Cultures human random control (ECACC-HRC) DNA
panel (Sigma, St. Louis, MO) to distinguish the predicted
mutation, with 95% confidence, from a polymorphism with
1% frequency as recommended [30].
Mutation prediction analyses: Missense mutations in GJA3
were  evaluated  for  pathogenicity  using  three  in  silico
prediction  algorithms:  Position-Specific  Scoring  Matrix
analysis  (PSSM),  Sorting  Intolerant  From  Tolerant
substitutions (SIFT) [31], and Polymorphism Phenotyping-2
(PolyPhen-2)  [32].  GJA3  amino-acid  sequences  were
retrieved from the Entrez protein database, and aligned by
means  of  the  ClustalW  multiple  sequence  alignment  web
server  [33].  The  hydrophobicity  profile  of  GJA3  was
determined  by  means  of  the  HMMTOP  transmembrane
topology prediction server [34], and structurally conserved
domains  located  using  the  Conserved  Domain  Database
(CDD) [35].
RESULTS
Linkage  analysis:  We  studied  a  5-generation  Caucasian
American  pedigree  (family  Sh)  segregating  autosomal
TABLE 1. PCR PRIMERS FOR MUTATION SCREENING OF GJA3.
Primer Location Strand Sequence (5′>3′) Amplicon
(bp)
GJA3-Ex2F1 Codons 128–134 Antisense CCCGCGACGAGGGATTGT 634
GJA3-Ex2R1 Intron-1 Sense GACGCTTGCACTTGTGTAGTGCC  
GJA3-Ex2F2 Codons 230–235 Antisense CTGGTCACGCCCTGCTTGAG 512
GJA3-Ex2R2 Codons 77–83 Sense TTCTGGGCGCTGCAGATCAT  
GJA3-Ex2F3 Codons 429–436 (Stop) Antisense TAGATGGCCAAGTCCTCCGGTCT 737
GJA3-Ex2R3 Codons 203–210 Sense TTCATCATCTTCATGCTGGCGGTG  
GJA3-Ex2F4 3′-UTR Antisense GAGACAGCCCTCAGCGACCA 563
GJA3-Ex2R4 Codons 361–367 Sense ACTCGCGCACGAGGCTGA  
               Primer pairs for amplification and sequencing of the coding region (exon-2) of GJA3 located on 13q.
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2256dominant cataract in the absence of other ocular or systemic
defects. Autosomal dominant inheritance was supported by
the  absence  of  gender  bias  or  skipping  of  generations.
Ophthalmic records described the cataract as congenital in at
least four affected individuals (III:I, IV:2, IV:6, and IV:8);
however, no slit-lamp images of the lens opacities pre-surgery
were available. Twenty-two members of the family (Figure
1), including eleven affected individuals were genotyped with
microsatellite  markers  at  11  candidate  loci  for  autosomal
dominant cataract on chromosomes 1q (GJA8), 2q (CRYGC,
CRYGD),  3q  (BFSP2),  11q  (CRYAB),  12q  (MIP),  13q
(GJA3),  16q  (HSF4),  17q  (CRYBA1),  19q  (LIM2),  21q
(CRYAA),  and  22q  (CRYBB1–3,  CRYBA4).  Following
exclusion of 10 of these loci (Z≤-2.0, θ=0.0–0.1), we obtained
significant evidence of linkage (Table 2) for marker D13S175
(Zmax=3.67, θmax=0.04) and D13S1316 (Zmax=2.80, θmax=0.0)
on  13q11-q12.  Haplotyping  of  the  pedigree  (Figure  1)
detected two affected females, IV:6 and IV:12, who were
obligate recombinants at marker D13S1236. Individual IV:12
was also recombinant at D13S175. No other recombinant
individuals were detected at the most centromeric marker
D13S1316,  suggesting  that  the  disease  locus  lay  in  the
physical  interval,  D13S1316-(0.17Mb)-D13S175,  which
contains the strong candidate gene GJA3.
Mutation detection: GJA3 (GeneID: 2700) comprises two
exons with exon-2 containing the entire coding region for a
435-amino-acid  protein.  Sequencing  of  exon-2  including
flanking 5′-intron and 3′-UTR boundaries in two affected
relatives detected a heterozygous G-to-A transition (Figure 2)
located at position 130 from the first base (A) of the translation
start (ATG) codon (c.130G>A). This single nucleotide change
was not present in the reference sequence and resulted in the
gain  of  an  Hsp92  II  restriction  site  (5′CATG↓).  PCR
amplification  and  restriction  fragment  length  analysis
Figure 1. Linkage analysis of autosomal dominant cataract segregating in a 5-generation Caucasian American pedigree (family Sh). A: Pedigree
and haplotype analysis showing segregation of 3 microsatellite markers on chromosome 13q listed in descending order from the centromere
(13p-tel). Squares and circles denote males and females respectively. Filled symbols denote affected status. B: Ideogram of chromosome 13
showing the cytogenetic location of the cataract locus.
TABLE 2. TWO-POINT LOD SCORES (Z) FOR LINKAGE BETWEEN THE CATARACT LOCUS AND CHROMOSOME 13 MARKERS.
      Z at θ=    
Marker Mb cM 0.00 0.05 0.10 0.20 0.30 0.40 Zmax θmax
D13S1316 20.68 0.00 2.80 2.50 2.20 1.58 0.95 0.35 2.80 0.00
GJA3 (c.130G>A) 20.71 6.55 6.02 5.46 4.24 2.88 1.35 6.55 0.00
D13S175 20.85 7.40 -∞ 3.67 3.46 2.68 1.70 0.66 3.67 0.04
D13S1236 22.70 4.20 -∞ 1.48 1.72 1.57 1.11 0.49 1.74 0.12
        Z values for markers on 13q listed in physical and genetic distances measured in Mb and cM, respectively, from the short-arm
        telomere (13p-tel).
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2257confirmed  the  presence  of  the  heterozygous  c.130G>A
transition in all affected members of family Sh, and its absence
in unaffected relatives (Figure 2). Moreover, when we tested
the c.130G>A change as a bi-allelic marker with a notional
frequency of 1%, in a two-point LOD score analysis of the
cataract  locus  (Table  2)  we  obtained  further  compelling
evidence of linkage to GJA3 (Zmax=6.55, θmax=0). Finally we
excluded  the  c.130G>A  transition  as  a  single  nucleotide
polymorphism  (SNP)  in  a  panel  of  192  normal  unrelated
control individuals (384 chromosomes) using allele-specific
restriction analysis described in Figure 2 (data not shown).
Taken  overall  our  genotype  and  sequence  data  strongly
suggested  that  the  c.130G>A  transition  represented  a
causative  mutation  rather  than  a  benign  SNP  in  linkage
disequilibrium with the cataract phenotype.
Figure 2. Mutation analysis of GJA3 in family Sh. A: Sequence
profile of the wild-type allele showing translation of valine (V) at
codon 44 (GTG) in exon 2. B: Sequence trace of the mutant allele
showing the heterozygous c.130G>A transition (denoted R by the
International Union of Pure and Applied Chemistry [IUPAC] code)
at the first base of codon 44 (ATG) that is predicted to result in a
missense substitution of methionine (M) for valine (p.V44M). C:
Restriction fragment length analysis on agarose gels showing gain
of an Hsp92 II site (5′CATG↓) that co-segregated with affected
individuals heterozygous for the mutant A-allele (167/174 bp) but
not with unaffected individuals homozygous for the wild-type G-
allele (341 bp).
Functional predictions: The c.130G>A transition occurred at
the first base of codon 44 (GTG>ATG) and was predicted to
result  in  the  missense  substitution  of  valine-to-mehionine
(p.V44M) at the level of protein translation. The predicted
p.V44M  substitution  represented  a  relatively  conservative
amino acid change, with the small non-polar side-group of
valine (CH3-CH-CH3) replaced by the larger non-polar side-
group of methionine (CH2-CH2-S-CH3). However, cross-
species alignment of GJA3 amino-acid sequences revealed
that p.V44 is phylogenetically conserved from Zebrafish to
man (Figure 3).
Based  on  the  hydrophobicity  profile  of  GJA3,  the
p.V44M substitution is likely located in the first extracellular
(EC-1)  loop  close  to  the  boundary  with  the  first
transmembrane (TM-1) domain (Figure 3). To evaluate the
functional  consequences  of  the  p.V44M  substitution  we
compared  it  to  all  the  other  missense  variations  so  far
identified  in  GJA3  using  three  sequence  homology  based
prediction algorithms (Table 3). PSSM analysis revealed a
marked decline in value from +5 to −1 confirming that the
predicted p.V44M substitution occurred less frequently than
expected in proteins with the conserved connexin superfamily
domain (CCD: pfam00029). SIFT analysis gave a score of
0.00 consistent with an “intolerant” amino-acid change, and
PolyPhen-2 analysis gave a score of 1.00 consistent with a
“probably damaging” change, further raising the likelihood of
GJA3 dysfunction.
DISCUSSION
Here we have identified a heterozygous transition (c.130G>A)
in exon-2 of GJA3 co-segregating with autosomal dominant
cataract linked to chromosome 13q in a Caucasian American
family. This missense mutation was predicted to result in a
conservative p.V44M substitution in the first extracellular
domain of GJA3 with damaging effects on protein function.
Recently, the same GJA3 mutation was detected by candidate-
gene  sequencing  in  a  Han  Chinese  family  segregating
autosomal dominant cataract described as central nuclear with
punctate  cortical  opacities  [36].  However,  no  supporting
linkage analysis or functional studies were performed. Our
data confirm recurrent association of the p.V44M substitution
in GJA3 with autosomal dominant cataract linked to 13q.
Currently,  at  least  19  different  heterozygous  coding
mutations in GJA3 (Table 3) have been detected in 22 families
worldwide making it one of the most frequently mutated genes
associated with autosomal dominant cataract. The resulting
opacities are usually described as nuclear or zonular/lamellar
often with a pulverulent (dustlike) or punctate appearance. All
but one of the known coding mutations in GJA3 are missense
substitutions  (Table  3)  that  are  located  toward  the  NH2-
terminal end of the protein containing the conserved connexin
domain  (CCD:  pfam00029)  and  the  gap-junction  channel
protein  cysteine-rich  or  conexin_CCC  domain  (CCD:
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2258pfam10582). Five of these missense substitutions, including
p.V44M identified here, are believed to be located in the first
extracellular (EC-1) domain of GJA3 (Figure 3). In addition
to  p.V44M,  two  other  missense  mutations  in  GJA3  are
recurrent  with  autosomal  dominant  cataract.  A  p.P59L
substitution in the first extracellular domain has been reported
in American and Danish families [37,38], whereas, a p.R76H
substitution in the second transmembrane domain has been
detected  in  Australian  and  Danish  families  [38,39].
Furthermore,  two  other  valine-to-methionine  substitutions
have been reported in GJA3. A p.V28M change in the first
transmembrane domain has been associated with autosomal
dominant cataract in an Indian family [40], and a p.V139M
change in the cytoplasmic loop has been associated with age-
related  cortical  cataract  in  a  Chinese  population  [41].
Interestingly, both p.V28M and p.V44M were predicted to be
probably damaging to GJA3 function, whereas, p.V139M was
predicted to be a benign or possibly damaging variant (Table
3).
So far no mutations in the mouse Gja3 gene have been
associated  with  spontaneous  or  chemically/radiologically
induced  forms  of  cataract.  By  contrast  a  homozygous
missense  substitution  (p.E42K)  in  rat  Gja3  underlies  a
spontaneous form of autosomal recessive nuclear cataract in
the SHRSPwch1.9Cat strain [42]. Knockout mice lacking Gja3
as a result of gene disruption also develop nuclear cataract
with  severity  of  lens  opacification  influenced  by  genetic
background [43,44]. However, hemizygous loss of Gja3 does
not elicit cataract in mice.
Mouse  Gja3  has  been  proposed  to  function  in  gap-
junction coupling of lens fiber cells [45]; the primary target
cells for cataract. In addition, Gja3 has been shown to form
active hemi-channels in dissociated mouse lens fiber cells
[46]. Structure-function prediction algorithms show that 18 of
19 reported missense substitutions in GJA3 are likely to be
damaging to protein function (Table 3). Functional expression
studies of one GJA3 missense mutant, p.N63S, in Xenopus
oocytes  revealed  that  it  exhibited  impaired  hemi-channel
activity in single oocytes, and failed to elicit gap-junction
coupling in paired oocytes [47]. While p.N63S is located in
the conserved tri-cysteine motif within the first extracellular
domain  of  GJA3,  p.V44M  identified  here  and  p.E42K
identified in the rat are located near the boundary between the
first extracellular domain and the first transmembrane domain
(Figure 3). Both p.V44M and p.N63S are associated with
autosomal dominant cataract, whereas, p.E42K is associated
with  autosomal  recessive  cataract.  In  general  mutations
underlying  autosomal  dominant  phenotypes  result  in
deleterious  gain-of-function  mechanisms,  whereas,  those
underlying  autosomal  recessive  phenotypes  elicit  loss-of-
function mechanisms. Further detailed functional expression
studies will be required to elucidate the precise pathogenic
mechanisms that link GJA3 mutations with cataract.
Figure  3.  Schematic  showing  gene
structure and protein domains of GJA3.
A:  Exon  organization  and  mutation
profile  of  GJA3.  The  entire  coding
region (435 amino-acids) is located in
exon-2.  Based  on  hydrophobicity
analysis [34], GJA3 has nine structural
domains  including:  a  cytoplasmic  N-
terminus  (NT),  4  transmembrane
domains (TM-1 – TM-4); 2 extracellular
loops (EC1, EC2), a cytoplasmic loop
(CL),  and  a  cytoplasmic  C-terminus
(CT).  The  relative  locations,  with
respect to the translation start codon, of
the  p.V44M  mutation  and  19  other
mutations  associated  with  autosomal
dominant  cataract  in  humans  are
indicated.  The  rat  p.E42K  mutation
associated  with  autosomal  recessive
cataract is also indicated. B: Amino-acid
sequence  alignment  of  the  first
extracellular  (EC-1)  domain  (amino-
acids  42–71)  from  human  GJA3  and
homologs  from  other  species.  Dots
denote identical amino-acids. Cysteine
residues  involved  in  hemi-channel
docking  are  underlined.  Missense
substitutions are shown in red.
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c.82G>A p.V28M +6/-1 0.00 0.970 TM-1 “Total, anterior capsular,
cortical”
India [40]
c.96C>A p.F32L +9/-1 0.00 0.999 TM-1 Nuclear pulverulent China [52]
c.98G>T p.R33L +8/-4 0.00 1.000 TM-1 Granular embryonal India [53]
c.130G>A p.V44M +5/-1 0.00 1.000 EC-1 Nuclear China [36]
c.130G>A p.V44M +5/-1 0.00 1.000 EC-1 ? USA This study
c.134G>C p.W45S +12/-4 0.00 1.000 EC-1 Nuclear China [54]
c.139G>A p.D47N +8/-1 0.01 1.000 EC-1 Nuclear China [55]
c.176C>T p.P59L +9/-5 0.00 1.000 EC-1 Nuclear punctate USA [37]
c.176C>T p.P59L +9/-5 0.00 1.000 EC-1 ? Denmark [38]
c.188A>G p.N63S +8/+1 0.00 0.833 EC-1 Variable pulverulent UK [17]
c.226C>G p.R76G +8/-4 0.00 0.961                   TM-2                   Total                                   India                        [40]
c.227G>A p.R76H +8/-2 0.00 1.000                   TM-2  Nuclear lamellar pulverulent           Australia          [39]
c.227G>A p.R76H +8/-2 0.00 1.000                   TM-2                    ?                                 Denmark                     [38]
c.260C>T p.T87M +6/-2 0.00 1.000 TM-2 “Pearl-box” India [56]
c.415G>A p.V139M - 0.07 0.818 CL Age-related cortical China [41]
c.560C>T p.P187L +8/-2 0.00 0.999 EC-2 Zonular pulverulent UK [57]
c.559C>T p.P187S +8/-2 0.00 0.961 EC-2 Nuclear pulverulent China [58]
c.563A>C p.N188T +6/-2 0.02 0.931 EC-2 Nuclear pulverulent China [59]
c.1137insC p.S380QfsX88 - - - COOH-
Term
Punctate UK [17]
        SIFT scores <0.05 are intolerant and scores ≥0.05 are tolerant. PolyPhen-2 scores >0.85 are probably damaging and scores 0.15–
        0.85 are possibly damaging.
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